Clin Chem: Saliva AMY1 copy number variation regulates age-related type 2 diabetes risk?
-
Last Update: 2020-07-27
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
!---- the copy number variation (CNV) in the salivary amylase gene (AMY1) regulates salivaalpha-amylase levels and is associated with post-meal blood glucose traitswhether AMY1-CNV plays a role in age-mediated insulin resistance (IR) changes is uncleartested AMY1-CNV with dual quantitative real-time polymerase chain reactions in two studies, the Puerto Rico Health Study (BPRHS, n- 749) and the Lipid-Lowering Drugs and Dietary Network Study (GOLDN, n-980), and the plasma metabolomics in BPRHSassess the relationship between age and blood sugar characteristics and type 2 diabetes (T2D) based on the high or low number of copies of the AMY1 gene to detect the interaction between AMY1-cnv and ageIn addition, the relationship between metabolites and AMY1-CNV and age interactions on T2D risk was also studiedfound that in two studies, subjects with low AMY1 copies had a positive correlation with agethere was little age correlation between T2D and participants with low number of starch 1 copies in BPRHS but high in starch 1 copymetabolic pathway enrichment analysis found that the glucose metabolic pathway is based on metabolites associated with IR and AMY1-CNV interaction with ageIn addition, in older participants, the number of copies of high starch 1 was often associated with lower levels of rnaycolic acid, red alginate and arabic acid, all of which were positively correlated with IRfindings support the role of AMY1-CNV in changing the relationship between age and IRindividuals with low anumber of AMY1 copies also increase their IR as they age.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.